此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

RISS Versus SPSIP Block in Modified Radical Mastectomy (RSMRM)

2026年6月19日 更新者:Ferit Yetik

Comparison of Rhomboid Intercostal-Subserratus Plane Block and Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia and Dermatomal Spread After Modified Radical Mastectomy: A Randomized Double-Blind Trial

This prospective randomized double-blind controlled trial aims to compare the postoperative analgesic efficacy and dermatomal spread of rhomboid intercostal-subserratus plane (RISS) block and serratus posterior superior intercostal plane (SPSIP) block in patients undergoing modified radical mastectomy. Postoperative pain scores, opioid consumption, rescue analgesic requirements, block-related complications, and quality of recovery outcomes will be evaluated.

研究概览

详细说明

Breast cancer surgery is frequently associated with moderate to severe postoperative pain, which may negatively affect recovery and increase opioid consumption. Ultrasound-guided fascial plane blocks have become an important component of multimodal analgesia strategies for breast surgery.

The rhomboid intercostal-subserratus plane (RISS) block and serratus posterior superior intercostal plane (SPSIP) block are recently described regional anesthesia techniques that may provide effective postoperative analgesia by blocking the lateral and posterior branches of the thoracic spinal nerves. However, comparative clinical evidence regarding their analgesic efficacy and dermatomal coverage in modified radical mastectomy remains limited.

This prospective randomized double-blind controlled trial will compare RISS block and SPSIP block in adult patients undergoing modified radical mastectomy under general anesthesia. Participants will be randomly allocated to receive either RISS block or SPSIP block before surgery. The primary objective is to compare postoperative opioid consumption. Secondary outcomes include postoperative pain scores, dermatomal sensory spread, time to first rescue analgesia, quality of recovery, opioid-related adverse events, and block-related complications.

研究类型

介入性

注册 (估计的)

80

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Female patients aged 18-75 years
  • ASA physical status I-III
  • Scheduled for elective unilateral modified radical mastectomy with axillary dissection under general anesthesia
  • Provision of written informed consent

Exclusion Criteria:

  • Anticoagulant therapy
  • Bleeding diathesis
  • Known allergy to local anesthetics or opioids
  • Infection at the block application site or previous surgery in the block area
  • Cognitive impairment preventing NRS assessment
  • Pregnancy or lactation
  • Chronic opioid use
  • Severe hepatic or renal failure
  • Refusal to participate in the study
  • Technical inability to perform the block or failed block

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:RISS Block
Patients will receive an ultrasound-guided rhomboid intercostal-subserratus plane (RISS) block before modified radical mastectomy for postoperative analgesia.
Ultrasound-guided rhomboid intercostal-subserratus plane block performed before modified radical mastectomy for postoperative analgesia.
实验性的:SPSIP Block
Patients will receive an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block before modified radical mastectomy for postoperative analgesia.
Ultrasound-guided serratus posterior superior intercostal plane block performed before modified radical mastectomy for postoperative analgesia.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Total Postoperative Opioid Consumption
大体时间:24 hours after surgery
Total opioid consumption during the first 24 hours after modified radical mastectomy.
24 hours after surgery

次要结果测量

结果测量
措施说明
大体时间
Intraoperative Remifentanil Consumption
大体时间:During surgery
Total intraoperative remifentanil consumption will be recorded and compared between groups.
During surgery
Postoperative Pain Scores
大体时间:0-24 hours after surgery
Postoperative pain intensity measured using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain.
0-24 hours after surgery
Compartmental Pain Scores Using Numeric Rating Scale
大体时间:0-24 hours after surgery
Numeric Rating Scale (NRS) score (0-10 points) measured separately for axillary pain, anterolateral chest wall pain, and surgical drain insertion site pain. A score of 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
0-24 hours after surgery
Dermatomal Sensory Block Distribution
大体时间:30 minutes after block performance
Number of dermatomes blocked, assessed by pinprick sensory testing 30 minutes after block performance. Higher values indicate wider sensory block distribution.
30 minutes after block performance
Quality of Recovery-15 Score
大体时间:24 hours after surgery
Quality of Recovery-15 (QoR-15) questionnaire score ranging from 0 to 150, where higher scores indicate better postoperative recovery and patient satisfaction.
24 hours after surgery
Block- and Opioid-Related Complications
大体时间:24 hours after surgery
Complications related to block performance and opioid use will be recorded.
24 hours after surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 首席研究员:Mürsel Ekinci, MD、Bursa City Hospital
  • 学习椅:Yusuf Alan, MD、Bursa City Hospital

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年6月19日

初级完成 (估计的)

2026年11月1日

研究完成 (估计的)

2026年11月1日

研究注册日期

首次提交

2026年6月12日

首先提交符合 QC 标准的

2026年6月17日

首次发布 (实际的)

2026年6月22日

研究记录更新

最后更新发布 (实际的)

2026年6月24日

上次提交的符合 QC 标准的更新

2026年6月19日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • MRM-2025-KAEK47
  • 2025-KAEK-47 (其他标识符:Clinical Research Ethics Committee of University of Health Sciences Bursa Faculty of Medicine)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅